Relay Therapeutics (RLAY) Cash from Operations (2019 - 2026)
Relay Therapeutics (RLAY) reported Cash from Operations of 51112000.0 for Q1 2026, up 30.18% year-over-year from 39261232.22 in Q1 2025, and down 13.92% quarter-over-quarter from 44865000.0 in Q4 2025.
Relay Therapeutics (RLAY) Cash from Operations (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has 8 years of Cash from Operations data on file, last reported at 51112000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 51112000.0, up 30.18% year-over-year; the trailing twelve-month figure through Mar 2026 was 213357000.0 (up 21.56% YoY), and the FY2025 annual result was 235455000.0, up 5.48% from the prior year.
- Cash from Operations fell to 51112000.0 in Q1 2026 per RLAY's latest filing, from 44865000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 44865000.0 in Q4 2025 and troughed at 89188000.0 in Q4 2023.
- A 5-year average of 62675294.12 and a median of 62119000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations tumbled 205.43% in 2022, then jumped 35.12% in 2024.
- A 5-year view of Cash from Operations shows it stood at 57079000.0 in 2022, then slumped by 56.25% to 89188000.0 in 2023, then jumped by 35.12% to 57868000.0 in 2024, then climbed by 22.47% to 44865000.0 in 2025, then fell by 13.92% to 51112000.0 in 2026.
- Business Quant data shows RLAY's Cash from Operations at 51112000.0 in Q1 2026, 44865000.0 in Q4 2025, and 62119000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | -51.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.11 Mn |
| Mar 31, 2026 | -51.11 Mn |
| Dec 31, 2025 | -44.87 Mn |
| Dec 31, 2025 | -44.87 Mn |
| Sep 30, 2025 | -62.12 Mn |
| Sep 30, 2025 | -62.12 Mn |
| Jun 30, 2025 | -55.26 Mn |
| Jun 30, 2025 | -55.26 Mn |
| Mar 31, 2025 | -73.21 Mn |
| Mar 31, 2025 | -73.21 Mn |
| Dec 31, 2024 | -57.87 Mn |
| Dec 31, 2024 | -57.87 Mn |
| Sep 30, 2024 | -75.08 Mn |
| Sep 30, 2024 | -75.08 Mn |
| Jun 30, 2024 | -65.83 Mn |
| Jun 30, 2024 | -65.83 Mn |
| Mar 31, 2024 | -50.32 Mn |
| Mar 31, 2024 | -50.32 Mn |
| Dec 31, 2023 | -89.19 Mn |
| Dec 31, 2023 | -89.19 Mn |